Filter
5899
Filtered Results: 5899
Text search:
drug
treatment
Featured
Recommendations
506
New Publications
1516
Language
Document type
No document type
3672
Studies & Reports
824
Guidelines
701
Manuals
234
Strategic & Response Plan
155
Fact sheets
115
Training Material
78
Situation Updates
58
Infographics
24
Resource Platforms
15
Brochures
14
Online Courses
7
App
1
Videos
1
Countries / Regions
India
368
Kenya
175
Global
165
South Africa
146
Western and Central Europe
131
Ethiopia
131
Uganda
123
Nigeria
112
Nepal
103
Tanzania
99
Liberia
93
Sierra Leone
89
Zambia
88
Malawi
87
Africa
83
Latin America and the Carribbean
78
Myanmar / Burma
74
Ghana
72
Bangladesh
72
Eastern Europe
71
Ukraine
65
Rwanda
61
Namibia
54
Philippines
49
Zimbabwe
47
Russia
45
Asia
42
Indonesia
41
Lesotho
38
Cambodia
37
South–East Asia Region
34
Mozambique
31
Botswana
30
Senegal
28
Congo, Democratic Republic of
27
Syria
26
Germany
25
Brazil
25
Eswatini/ Swaziland
23
Colombia
21
Burkina Faso
20
East and Southern Africa
20
South Sudan
20
Venezuela
17
West and Central Africa
17
USA
16
Middle East and North Africa
16
Cameroon
14
Eastern Europe and Central Asia
14
Haiti
13
Albania
12
Pakistan
12
Tajikistan
11
Guinea
11
Georgia
11
Thailand
10
Argentina
10
China
9
Afghanistan
9
Sudan
9
Peru
8
Vietnam
8
Yemen
7
North Macedonia
6
Benin
6
Armenia
6
Bolivia
6
Moldova
6
Angola
6
Mexico
5
El Salvador
5
Western Pacific Region
5
Lebanon
5
Papua New Guinea
5
Iraq
5
Somalia
5
Laos
4
Estonia
4
Guinea-Bissau
4
Jordan
4
Paraguay
4
Jamaica
4
United Kingdom
4
Southern Africa
4
Sri Lanka
4
Central African Republic
4
Libya
4
Bhutan
4
Ecuador
4
Timor Leste/ East Timor
3
Turkey
3
Iran
3
Fiji
3
Kyrgyzstan
3
Uzbekistan
3
Morocco
3
North America
3
Spain
3
Palestine
3
Mali
3
Switzerland
2
Serbia
2
Kazakhstan
2
Chile
2
Canada
2
Mongolia
2
Hungary
2
Saudi Arabia
2
Portugal
2
Belarus
2
Romania
2
Poland
2
Madagascar
2
North Korea
1
Australia
1
Gambia
1
Singapore
1
Malaysia
1
Qatar
1
Bulgaria
1
Italy
1
Lithuania
1
Ireland
1
Gabon
1
Uruguay
1
Turkmenistan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Côte d’Ivoire / Ivory Coast
1
Egypt
1
Greece
1
Honduras
1
Chad
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
2234
Clinical Guidelines
556
Public Health
272
Women & Child Health
219
Key Resources
93
Capacity Building
92
Pharmacy & Technologies
59
Annual Report MEDBOX
1
Toolboxes
HIV
736
TB
677
Mental Health
634
AMR
282
COVID-19
240
NTDs
210
Pharmacy
179
NCDs
133
Caregiver
111
Ebola
93
Rapid Response
90
Refugee
83
Conflict
63
Planetary Health
62
Disability
60
Global Health Education
48
Health Financing Toolbox
29
Polio
23
Specific Hazards
19
Cholera
19
Natural Hazards
18
Zika
16
Social Ethics
15
Health Financing
1
Accessed: 02.05.2020
Coronaviruses are a large family of viruses that are known to cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS).
The Global Fund’s product and delivery outlook shows the overall impact of COVID-19 on health product supply chains for Global Fund grants has increased from "low to moderate" to "moderate."
We as a large world community are facing an extraordinary challenge: keeping healthy against the threat of rapidly spreading novel Covid-19 virus. Starting with flu-like symptoms, the virus attacks the airways leading to severe breathing difficulties in the m ost vulnerable, that is, those whose im ...
While many of the countries hit by the COVID-19 in the first few months of the year are now beginning to relax lockdown measures as infection and death rates fall, in the regions most affected by HIV, TB and malaria, such as Africa, South Asia and Latin America, the pandemic continues to accelerate....
This guideline document lays out the indicators for monitoring the 2016 Political Declaration on ending AIDS. The Global AIDS Monitoring (GAM) process has been often referenced as a benchmark for successful international accountability mechanisms.
Updated 10 August 2020
This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, and are preferably in the WHO Model Lists of Essent...
: interim guidance, 17 February 2021
This document provides interim guidance on the management of the blood supply in response to the pandemic outbreak of coronavirus disease (COVID-19). It emphasizes the importance of being prepared and responding quickly and outlines key actions and measures that...
UNAIDS report on the global AIDS epidemic shows that 2020 targets will not be met because of deeply unequal success; COVID-19 risks blowing HIV progress way off course. Missed targets have resulted in 3.5 million more HIV infections and 820 000 more AIDS-related deaths since 2015 than if the world w...
This report reviews the latest evidence on what works to reduce HIV-related stigma and discrimination through key programmes to reduce stigma and discrimination and increase access to justice in the six settings of focus for the Global Partnership. It includes guidance for national governments and k...
This publication marks the 25th anniversary of the Beijing Declaration and Platform for Action. It is dedicated to the women leaders and allied community mobilizers who have devoted their lives to advancing the human rights and dignity of all people affected by the HIV epidemic, and to opposing soci...
This is an abridged version of the 2019 Standards containing the evidence-based recommendations most pertinent to primary care. The tables and figures have been renum-bered from the original document to match this version. The complete 2019 Standards of Care do...
Expert Consensus Report for Emergency Centres in
Western Cape
Integrated Management of Acute Malnutrition National Guidelines
Applying the evidence of what works from HIV-related stigma and discrimination in six settings to the COVID-19 response
This brief provide evidence-informed guidance to countries on the intersection of stigma related to HIV and COVID-19 in national responses.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV‑2) causing coronavirus disease 2019 (COVID-19) has reached pandemic levels;
Patients with cardiovascular (CV) risk factors and established cardiovascular disease (CVD) represent a vulnerable population when suffering from COVID-19;
Patien...
PlosOne January 20, 2021
https://doi.org/10.1371/journal.pone.0241899
Antibiotic fixed dose combinations (FDCs) can have clinical advantages such as improving effectiveness and adherence to therapy. However, high use of potentially inappropriate FDCs has been reported, with implications for antim...
